Related Experiment Video
Updated: Aug 16, 2026

Visualization of Amyloid β Deposits in the Human Brain with Matrix-assisted Laser Desorption/Ionization Imaging Mass Spectrometry
Published on: March 7, 2019
Amino-terminally truncated Abeta peptide species are the main component of cotton wool plaques
Leticia Miravalle1, Miguel Calero, Masaki Takao
1Indiana Alzheimer Disease Center, Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA.
Abstract:
Cotton wool plaques (CWPs) are round lesions that lack a central amyloid core. CWPs have been observed in individuals affected by early-onset familial Alzheimer disease (FAD) associated with mutations in the presenilin 1 (PSEN1) gene. Here we present the characterization of the amyloid-beta (Abeta) peptides deposited in the brain of an individual affected by FAD carrying the novel missense (V261I) mutation in the PSEN1 gene. Matrix-assisted laser desorption ionization time-of-flight mass spectrometry was used to determine the Abeta peptide species present in the cerebral and cerebellar cortices, in leptomeningeal vessels, and in CWPs isolated by laser microdissection (LMD). Our results indicate that amino-terminally truncated Abeta peptide species ending at residues 42 and 43 are the main Abeta peptides deposited in brain parenchyma and LMD-CWPs in association with the PSEN1 V261I mutation. Full-length Abeta1-42 and Abeta1-43 peptide species were underrepresented. CWPs were not found to be associated with vessels and did not contain Abeta1-40 peptides, the main component of the vascular deposits. Although Abeta deposits were present mostly in the form of CWPs in the cerebral cortex and as diffuse deposits in the cerebellar cortex, a similar array of amino-terminally truncated Abeta peptide species was seen in both cases. The biochemical data support the concept that parenchymal and vascular amyloid deposits are associated with a different array of Abeta peptide species. The generation and parenchymal deposition of highly insoluble amino-terminally truncated Abeta peptides may play an important role in the pathogenesis of AD and must be taken into consideration in developing new diagnostic and therapeutic strategies.
Insights
Researchers identified specific amyloid-beta (Abeta) peptides in familial Alzheimer disease (FAD) brains with a novel PSEN1 mutation. Amino-terminally truncated Abeta peptides, not full-length ones, dominated parenchymal and cotton wool plaque deposits.
Area of Science:
- Neuroscience
- Biochemistry
- Genetics
Background:
- Cotton wool plaques (CWPs) are Alzheimer disease (AD) lesions lacking amyloid cores, observed in early-onset familial AD (FAD) linked to PSEN1 mutations.
- The specific amyloid-beta (Abeta) peptide composition in CWPs associated with novel PSEN1 mutations remains incompletely understood.
Purpose of the Study:
- To characterize the Abeta peptide species deposited in the brain of an FAD individual with a novel PSEN1 V261I mutation.
- To investigate the Abeta composition of CWPs and compare it with parenchymal and vascular deposits.
Main Methods:
- Laser microdissection (LMD) was used to isolate CWPs.
- Matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS) analyzed Abeta peptides in brain parenchyma, vessels, and CWPs.
Main Results:
- Amino-terminally truncated Abeta peptides ending at residues 42 and 43 were the predominant species in brain parenchyma and LMD-isolated CWPs.
- Full-length Abeta1-42 and Abeta1-43 were underrepresented, while Abeta1-40 was absent in CWPs but present in vascular deposits.
- Similar truncated Abeta peptide profiles were observed in CWPs (cerebral cortex) and diffuse deposits (cerebellar cortex).
Conclusions:
- Parenchymal and vascular amyloid deposits are characterized by distinct Abeta peptide profiles.
- The generation and deposition of insoluble, amino-terminally truncated Abeta peptides may be crucial in AD pathogenesis.
- These findings have implications for developing novel diagnostic and therapeutic strategies for AD.
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Alzheimer Disease ll: Pathophysiology

